Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Neoplasms × durvalumab × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 21 Breast 6 Gastrointestinal 5 Genitourinary 3 Thoracic 2 Head & Neck 2 Sarcoma 1 Other solid neoplasm 1 Lymphoid 1 Dermatologic 1

Conditions

Sarcoma 6 Melanoma 3 Hemangiosarcoma 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Osteosarcoma 2 Neoplasms 2 Vascular Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Testicular Neoplasms 1 Tertiary Lymphoid Structures 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Synovial 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, T-Cell, Cutaneous 1 Liposarcoma 1 Leiomyosarcoma 1 Kidney Neoplasms 1 Histiocytoma, Malignant Fibrous 1 Hemangioendothelioma, Epithelioid 1 Head and Neck Neoplasms 1 Glioma 1 Glioblastoma 1 Endometrial Neoplasms 1

Interventions

Filgrastim 11 Cyclophosphamide 10 Carboplatin 9 Doxorubicin 8 Ifosfamide 7 Peripheral Blood Stem Cell Transplantation 6 Paclitaxel 6 pembrolizumab 5 Specimen Handling 5 Gemcitabine 5 Temozolomide 4 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 Etoposide 4 Cisplatin 4 Amifostine 4 fludarabine 3 Trastuzumab 3 Taxes 3 Melphalan 3 Fulvestrant 3 Docetaxel 3 Bevacizumab 3 pazopanib 2 palbociclib 2 eribulin 2 entrectinib 2 belinostat 2 balstilimab 2 atezolizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03085225 2025-09-04

TRAMUNE

Institut Bergonié

Phase 1 Completed

40 enrolled 23 charts

GynecologicSarcoma

Ovarian Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡